PANCREATIC CANCER NEWS TIPS & FEATURES


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s Clinical Trial News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.
A Global Phase 3 Study Investigating Cancer Stemness Inhibitor Napabucasin in Patients With Metastatic Pancreatic Cancer

August 15, 2017

A Global Phase 3 Study Investigating Cancer Stemness Inhibitor Napabucasin in Patients With Metastatic Pancreatic Cancer

By cancerconnect cancerconnect

A new clinical study will investigate napabucasin – an orally administered investigational agent designed to inhibit cancer stemness pathways by targeting STAT3 – in combination with standard of care (nab-paclitaxel plus gemcitabine) in patients with metastatic pancreatic cancer. Patients in the trial will be randomized in a 1:1 ratio to receive either two daily doses […]

View full entry

Tags: Cancer Stemness Inhibitor Napabucasin, clinical trial, News Tips and Features, News Tips and Features Other, Pancreatic Cancer


Encouraging Overall Survival and Well-Being for Xilonix™ in Advanced Colorectal Cancer

February 19, 2015

Encouraging Overall Survival and Well-Being for Xilonix™ in Advanced Colorectal Cancer

By Anonymous User anonymous_user_10987

The investigational agent Xilonix™ appears safe and effective for patients with advanced colorectal cancer. These findings were presented at the 2015 Gastrointestinal Cancers Symposium, January 15–17, in San Francisco, California.[1] According to estimates from the American Cancer Society, 93,090 cases of colon cancer and 39,610 cases of rectal cancer will be diagnosed in 2015. Colorectal […]

View full entry

Tags: advanced colorectal cancer, clinical trial, Colon Cancer, colon cancer treatment, colorectal cancer, crc, interleukin, News Tips and Features, News Tips and Features Other, Rectal Cancer, Recurrent/Relapsed Rectal Cancer, Stage IV (D)/Relapsed Colon Cancer


View more articles like this
More news and in-depth Colon Cancer information

CONDITIONS OF THE GI TRACT